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Significance of the research 1 
The research investigated the impact of two polyphenol supplements 2 
on high intensity cycling performance. To date, little research has 3 
been undertaken with antioxidant polyphenol supplements regarding 4 
exercise performance, particularly CherryActive and Pycnogenol®. 5 
This is the first study to investigate the supplementation of either 6 
CherryActive or Pycnogenol® on gross efficiency and 20 km cycling 7 
time trial performance. Findings suggest that the Pycnogenol®8 
supplement may have a small effect on performance during the final 9 
stages of a 20 km TT, however further research with greater dosages 10 
are needed to clarify the ergogenic potential of the supplements.  11 
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Abstract  49 
The primary purpose of the study was to establish the effects of 50 
commercially available polyphenol-rich antioxidant supplements, 51 
Pycnogenol® with added bioflavonoids (PYC-B) and CherryActive 52 
(CHA), on 20 km cycling performance. Using a double-blind 53 
counterbalanced, repeated-measures design, nine male cyclists or 54 
triathletes (32.1 ± 11.2 years; maximal aerobic capacity 4.2 ± 0.7 55 
Lmin¹; maximal power output 391.7 ± 39.5 watts) consumed 200 56 
mg of CHA, 120 mg of PYC-B, or 200 mg of placebo (PLA) capsules, 57 
2 days before and on the day of each experimental trial. The 58 
experimental trials consisted of four 5 minute stages at 40%, 50%, 59 
60%, and 70% maximal power output (Wmax), followed by a 20 km 60 
time trial (TT). Statistical analyses revealed no significant differences 61 
between trials for heart rate, respiratory exchange ratio, gross 62 
mechanical efficiency, oxygen consumption, or blood lactate, at any 63 
of the intensities completed during the initial 20 minute phase of the 64 
trial (p > .05). Final 20 km TT times were not significantly different 65 
between trials (p = .115), but, compared to PLA, PYC-B did 66 
significantly increase power output by 6.2% over the final 5 km of the 67 
TT (p = .022). The study suggests that PYC-B could be beneficial 68 
towards the end of an intense bout of cycling exercise. However, as 69 
total 20 km time was not significantly different between trials the 70 
doses used are unlikely to benefit 20 km cycling time trial 71 
performance.  72 
73 
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Abbreviations  77 
PYC = Pycnogenol®78 
CH = Cherries79 
PYC-B = Pycnogenol with added bioflavonoids. 80 
CHA = CherryActive 81 
FR = Free radicals 82 
AO = Antioxidants 83 
VO2 = Oxygen uptake 84 
HI = High intensity 85 
O2 = Oxygen 86 
NO = Nitric oxide 87 
TT = Time trial 88 
MAP = Maximal aerobic power test 89 
PLA = Placebo  90 
Cm = Centimetres 91 
Kg = Kilograms 92 
RER = Respiratory exchange ratio 93 
Blac = Blood lactate 94 
Wmax = Maximal power output 95 
GME = Gross mechanical efficiency  96 
ES = Effect size97 
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Introduction 101 
When undertaking endurance exercise at a high intensity (HI), the 102 
exercising muscles produce free radicals (FR) causing cellular 103 
damage [1, 2]. Free radicals accumulate due to the greater oxygen 104 
uptake (VO2) associated with HI exercise, and appear to impair 105 
skeletal muscle contraction, accelerating fatigue and diminishing 106 
performance [1, 3, 4]. Fatigue in HI exercise may also arise from 107 
circulatory limitations as the exercising muscles fail to receive a 108 
sufficient oxygen (O2) supply in order for HI performance to be 109 
sustained [5, 6]. To offset fatigue during HI exercise, recent research 110 
has suggested that performance could be improved through 111 
nutritional interventions which simultaneously combat FR damage 112 
and promote blood flow [4]. Various polyphenols appear to stimulate 113 
these antioxidant (AO) and vasodilatory effects [7, 4]. 114 
Adding AO-rich polyphenols to the diet may assist the bodys own 115 
AO system to counteract FR damage and the associated muscular 116 
fatigue [8-10]. Furthermore, polyphenols stimulate nitric oxide (NO) 117 
production within the cell walls, encouraging blood vessels to dilate 118 
[7, 12]. This could be beneficial during HI performance as NO 119 
enhanced vasodilation has been shown to enhance blood flow to the 120 
working muscles, which is essential if a high level of exercise 121 
performance is to be maintained [13, 6]. The combination of AO 122 
activity and enhanced vasodilation may be particularly beneficial in 123 
situations where a high level of FR damage is possible, such as 124 
when undertaking HI exercise [8, 11]. 125 
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It has been suggested that consuming nutrients that exert containing 126 
a variety of AOs are more beneficial in an attempt to counteract the 127 
FR damage caused by exercise-induced oxidative stress compared 128 
to singular AO nutrients (e.g. Vitamin C), potentially aiding HI 129 
exercise performance [9, 11]. Two such mixtures are Pycnogenol®130 
(PYC) and Cherries (CH). There are numerous polyphenols in PYC, 131 
including several proanthocyanidins, which produce a powerful 132 
mixture displaying AO and vasodilatory effects [12, 14, 15]. It has 133 
been shown that even a single dose of PYC (³100 mg) has 134 
significant effects on blood flow [16]. Three studies have reported 135 
that PYC supplementation can offset muscular fatigue and prolong 136 
time to exhaustion in exercise trials involving HI running [17] and 137 
cycling [18, 19]. However, whether or not PYC supplementation can 138 
lead to improvements in time trial (TT) tests, which are similar to race 139 
performance and are therefore considered superior tests, has not 140 
been investigated [20].  Similarly, the numerous polyphenols present 141 
in CH including anthocyanins, catechin and kaempferol have AO 142 
effects [21]. Anthocyanins in particular are found in large quantities in 143 
CH and have been shown to have powerful vasodilatory effects [22].   144 
Due to cherries AO capabilities, two recent studies found that 145 
supplementing with CH juice for 5 days can alleviate muscle damage 146 
following intense running exercise and boosts total antioxidant 147 
capacity [23, 24]. However, neither study measured the effect of CH 148 
juice on race time, therefore whether CH can directly enhance HI 149 
exercise performance remains unclear.   150 
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The majority of similar studies have employed longer protocols 151 
ranging from 5-30 days [2, 9, 17, 23, 24] whereas elite cyclists seem 152 
to prefer shorter protocols. Therefore the purpose of this study is to 153 
determine whether the acute ingestion of two polyphenol mixtures, 154 
Pycnogenol® (with added bioflavonoids; PYC-B) and/or CherryActive 155 
(CHA) for 3 days will significantly improve physiological measures 156 
during sub-maximal cycling and enhance subsequent 20 km TT 157 
performance in moderately trained cyclists and triathletes. The 158 
effects on power output during the final 5 of the TT are of particular 159 
interest as skeletal muscle fatigue will likely be more evident at this 160 
point, partly due to increased FR production, acidosis and increased 161 
demand on the circulatory system [3, 6 11]. It is hypothesized that 162 
both PYC-B and CHA will improve gross mechanical efficiency, 163 
enhance lactate efflux during sub-maximal cycling and improve 20 164 
km TT performance. 165 
166 
Method   167 
Participant characteristics  168 
Nine moderately trained cyclists and triathletes completed the study 169 
(Age: 32.1 ± 11.2 years, Height; 179.7 ± 5.9 cm, weight: 80.2 ± 8.6 170 
kg, VO2max: 4.2 ± 0.7 Lmin¹, maximal power output: 391.7 ± 39.5 171 
watts). All participants were male, >3 years competitive cycling 172 
experience and were familiar with time trials and cycling distances of 173 
³20 km. The study was reviewed by the University of Portsmouths 174 
BioSciences Research Ethics Committee. 175 
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176 
Study design  177 
A double blind repeated measures crossover design was employed 178 
with the participants ingesting one of three supplements, CHA, PYC-179 
B or a placebo (PLA) in three separate trials. CHA contained dried 180 
montmorency cherries which provided 216 mg of polyphenols 181 
(CherryActive, Twickenham, UK), PYC-B contained 120 mg of 182 
Pycnogenol® and 600 mg of citrus bioflavonoids (Horphag Research 183 
Ltd, NBTY, Warks, UK) and the placebo contained 1g of maltodextrin 184 
(PSP22 orange, Science in Sport Ltd. Lancashire, UK). The trial 185 
orders were allocated using a partial counter-balance with 6 186 
participants fully counterbalanced and the remaining 3 partially 187 
counter-balanced. The participants visited the University on 4 188 
occasions, firstly, to record their physical characteristics and to 189 
complete a maximal aerobic power test (MAP). The participants 190 
completed three experimental trials at a similar time of day, each 191 
separated by ³5 days at the University of Portsmouths exercise 192 
laboratory. Each trial consisted of 20 minutes of progressive intensity 193 
cycling and a 20 km TT on an electronically braked cycle ergometer 194 
(Velotron, Racermate Inc. Seattle).  195 
196 
Procedures  197 
Preliminary measures 198 
The participants first trial at the laboratory was a MAP test. Initially, 199 
participants height (cm) (Harpenden portable stadiometer, Holtain, 200 
UK) and body mass (kg) (770, Seca, Germany) were recorded. 201 
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Participants were fitted with a heart rate monitor (T31, Polar, UK) and 202 
a face mask (7400 Series, Hans Rudolph, USA) attached to an 203 
breath-by-breath expired gas analyser (Cosmed, Italy). This same 204 
procedure and equipment was used in all MAP tests and 205 
experimental trials.  206 
An initial workload of 50 watts was set on the ergometer using their 207 
preferred cadence. The workload was increased by 25 watts every 208 
60 seconds until the participant voluntarily stopped or was unable to 209 
continue cycling at >70 revmin¹ [25]. Participants were deemed to 210 
have reached VO2max when they could not maintain cycling at >70 211 
revmin¹ for 15 seconds and HR was ³90% of age-predicted 212 
maximum. The mean VO2 attained over the final 60 seconds of the 213 
trial was considered as VO2max and the highest power output attained 214 
for a given 60 second increment was considered the participants 215 
Wmax [26].  216 
217 
Experimental trials and supplements 218 
Three experimental trials were completed with a different supplement 219 
consumed prior to each. For three days (two days before and on the 220 
day of the trial) participants consumed one of three supplements; 221 
PYC-B, CHA or a PLA, consuming the other two supplements in the 222 
subsequent two trials. The supplements were provided in capsule 223 
form of the same size and the contents were of similar colour to 224 
maintain the blinding of the study. The participants were instructed to 225 
consume two capsules together with a meal. Timing of intake was 226 
10 
standardized across trials by instructing participants to consume the 227 
supplements at the same time of day equivalent to two to three hours 228 
prior to each trial.  229 
Prior to testing, participants were provided with food diaries and 230 
instructed to detail their food and fluid intake on the two days before 231 
and on the day of their first experimental trial. They were then told to 232 
repeat this diet over the same time period prior to the subsequent 233 
trials. A list detailing foods with a high quantity of polyphenols were 234 
provided to participants so that these were not consumed in the 24 235 
hours leading up to the experimental trials. Participants were 236 
instructed to avoid undertaking strenuous exercise and consuming 237 
caffeine, alcohol or any vitamin supplement in the 48 hours prior to 238 
each experimental trial. Participants were asked to arrive at the 239 
laboratory in a fed state having eaten a meal of similar macronutrient 240 
content two to three hours prior to each trial.  241 
The initial phase of the experimental trial involved cycling at four 5-242 
minute incremental stages, each corresponding to 40, 50, 60 and 243 
70% of the participants Wmax. The Cosmed system recorded heart 244 
rate (HR), expired gas concentrations (oxygen uptake [VO2] and 245 
carbon dioxide production [VCO2]) continuously. A 20 µl blood 246 
sample was obtained via a finger-prick sample before the end of 247 
each stage to determine blood lactate (Blac) concentrations (Biosen 248 
C_line Sport, EFK-Diagnostics GmbH, UK). Gross mechanical 249 
efficiency (GME) was calculated for each stage to determine if the 250 
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supplements affected the energy cost of sub-maximal cycling using 251 
the following equation:  252 
Mechanical power (kcalmin-1) / metabolic power (kcalmin¹) X 100 = 253 
GME %. Efficiency was measured.  254 
Once the 20 minutes was completed the participants had a 10 minute 255 
break before starting the 20 km TT. The TT was self-paced and 256 
participants were instructed to complete the course as quickly as 257 
possible. The only feedback the participants received was distance, 258 
which was projected onto a screen in front of them. Expired gases 259 
and HR were recorded continuously throughout the TT, along with 260 
power output (Watts), speed (kmh¹), cadence (revmin¹) and time 261 
(milliseconds) using the Velotron computer software. A final Blac262 
measure was taken in the last 0.5 km of the TTs.  263 
Data analysis 264 
Statistical analyses were performed using PASW statistics version 18 265 
for Microsoft Windows, and results are presented as mean ± SD. 266 
Coefficient of variation (CV) was established for time to complete 20 267 
km. All data were checked for normality and one and two way 268 
analyses of variance (ANOVA) with repeated measures were 269 
applied. If the ANOVA found significant differences, paired samples t-270 
tests with bonferroni correction were applied to determine which 271 
conditions were significantly different. Statistical power was 272 
calculated and effect sizes were calculated using partial eta and 273 
Cohens d [27]. The alpha was set at p < .05. 274 
275 
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Results 276 
Sub-maximal data 277 
Due to equipment failure, data for the sub-maximal portion of the trial 278 
was only collected for 6 participants. Table 1 displays the descriptive 279 
data for the 5 parameters assessed. There were no significant 280 
differences in GME at any of the intensities (40, 50, 60, 70% Wmax) 281 
during between trials (p = .952, eta-squared = .05, power = .11). 282 
Mean VO2 for the 5 minute stages was also not significantly different 283 
between trials (p = .966, eta-squared = .04, power = .10). There were 284 
no differences in RER (average value over the 5 minute stage) at any 285 
of the intensities completed during the trials (p = .562, eta-squared = 286 
.14, power = .27), or for HR at the end of each stage (p = .064, eta 287 
squared = .21, power = .71). The Blac data was collected from eight 288 
participants and there were no differences in Blac at any of the 289 
intensities between trials (p = .742, eta-squared = .08, power = .21). 290 
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Table 1. HR, Blac, GME, V O2 and RER data collected for each 5 minute stage (mean ± SD).  291 
Measure % of Wmax
 40 50 60 70 
 PLA CHA PYC-B PLA CHA PYC-B PLA CHA PYC-B PLA CHA PYC-B 
HR 
(bmin¹) 
119.4 ± 14.1 117.6 ± 11.9 120.9 ± 12.9 134.2 ± 16.6 132.6 ± 13.7 134.2 ± 15.4 151.1 ± 17.2 148.2 ± 14.9 157.8 ± 16.4 164.9 ± 17.7 161.9 ± 16.2 162.4 ± 15.3 
Blac 
(mmoll¹) 
2.1 ± 0.8 1.8 ± 0.3 2.2 ± 0.7 2.6 ± 1.2 2.2 ± 0.9 3.1 ± 1.4 3.7 ± 1.7 2.9 ± 0.8  3.4 ± 1.4 5.6 ± 2.3 4.8 ± 1.0 5.6 ± 1.7 
GME (%) 21.1 ± 1.9 20.9 ±1.6 21 ± 1.1 21.6 ± 1.8 21.4 ± 1.0 21.3 ± 1.1 22 ± 1.3 22.9 ± 0.9 22 ± 1.2 22.4 ± 1.5 22.3 ± 1.0 22.3 ± 1.2 
V O2 
(Lmin¹) 
2.18 ± 0.29 2.19 ± 0.17 2.19 ± 0.15 2.65 ± 0.38  2.64 ± 0.20 2.67 ± 0.24 3.10 ± 0.39 3.14 ± 0.28 3.08 ± 0.29 3.54 ± 0.41 3.54 ± 0.33 3.53 ± 0.31 
RER 0.92 ± 0.03 0.93 ± 0.03 0.91 ± 0.03 0.97 ± 0.06 0.97 ± 0.02 0.97 ± 0.03 0.99 ± 0.06 0.99 ± 0.04 0.99 ± 0.03 1.00 ± 0.04 1.02 ± 0.01 1.02 ± 0.03 
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Time trial data 292 
Time 293 
The average CV across the 20 km time trials was 1.68%. Mean ± SD 294 
time for the 20 km was PYC-B: 1990.07 ± 93.18 s, PLA: 2030.30 ± 295 
124.73 s and CHA: 2008.56 ± 97.50 s (Figure 1). Time taken to 296 
complete the 20 km TT was not significantly different between trials 297 
(p = .115, eta-squared = .24, power = .43). Effect size for the mean 298 
difference between the PYC-B and PLA trials was calculated at 0.46 299 
and 0.37 for the CHA and PLA trials.  300 
301 
302 
Figure 1 Time taken (s) to complete 20 km for the 3 trials. 303 
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Power output  308 
Mean ± SD power output over the 20 km was PYC-B: 250.58 ± 27.89 309 
W, CHA: 244.98 ± 29.29 W and PLA: 240.69 ± 35.31 W. There was 310 
no significant difference in 20 km power output between the trials (p311 
= .171, eta-squared = .20, power = .35). However, there was a 312 
significant difference between trials in the final 5 km of the TT (p = 313 
.038, eta-squared = .34, power = .63) with a paired samples t-test 314 
revealing that power output was significantly greater during PYC-B 315 
compared to PLA (p = .022, ES = .45) (Figure 2). Mean ± SD in the 316 
final 5 km was PLA: 247.29 ± 36.98 W and PYC-B: 263.77 ± 25.1 W.  317 
318 
319 
Figure 2 Mean power output (W) for the final 5 km of the 3 trials.* 320 
significantly greater power output compared to PLA.321 
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Blood lactate and Heart rate 326 
No significant differences were observed between trials for HR at 10, 327 
15, 18 and 20 km (p = .160, eta-squared = .16, power = .64). Blac, 328 
collected at 19.5 km, were not significantly different between trials (p329 
= .859, eta-squared = .19, power = .07) (Table 2).  330 
331 
Table 2. Blac (mmoll¹) at 19.5 km into the 3 trials and average HR 332 
(bmin¹) at 10, 15, 18 and 20 km of the TT (mean ± SD).   333 
 PLA CHA PYC-B 
Blac  6.66 ± 2.58 6.77 ± 2.03 6.41 ± 2.23 
HR10 163 ± 13.64  158.8 ± 11.42 161.77 ± 8.96 
HR15 167 ± 14.86 161.44 ± 10.10 165.33 ± 8.39 
HR18 167.44 ± 10.19 166.66 ± 10.23 168.44 ± 8.45 
HR20 176.66 ± 12.19 175.22 ± 10.4 178.11 ± 10.82 
334 
Discussion 335 
The primary aim of the study was to determine if supplementing with 336 
2 different polyphenol mixtures (PYC-B and CHA) for only 3 days 337 
could improve cycling TT performance. It was found that after PYC-B 338 
supplementation, participants were able to generate a significantly 339 
greater power output over the final 5 km by 6.2% (Figure 2). 340 
However, overall 20 km TT performance was not significantly 341 
different between trials. No performance benefits were observed at 342 
any time point following CHA supplementation. Furthermore, neither 343 
PYC-B nor CHA had any effect on GME, HR, RER, VO2 or Blac at 40, 344 
50, 60 and 70% of Wmax when compared to the PLA. The only 345 
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physiological measures taken during the TT was HR and Blac at 19.5 346 
km, which were both not significantly different between the 3 trials.  347 
In previous similar studies, acute PYC consumption extended time to 348 
fatigue in cycling trials [17, 18] and enabled participants to run for 349 
29.6% longer following 30 days of PYC (200 mg/day) 350 
supplementation [16]. This however is the first study to assess the 351 
effects of a PYC based supplement during a performance test and 352 
supplementing for as little as 3 days. Although there was no 353 
statistical difference between trials, a small effect size of .46 was 354 
observed for 20 km time in favour of PYC-B. Participants completed 355 
the 20 km 1.98% faster during the PYC-B trial compared to the PLA. 356 
It is possible that any small effects resulting from the supplements 357 
could have been better detected amongst a group of elite cyclists 358 
since elite cyclists have demonstrated a CV of 1.1% for the 20 km TT 359 
[28] compared to the 1.68% demonstrated in this study.  360 
The significant improvement in the last 5 km of the TT in PYC-B 361 
could be related to the greater intensity of exercise being performed. 362 
This is demonstrated by the increase in HR over this time (see table 363 
2). The increase in intensity would have decreased muscle pH and 364 
increased VO2, causing the exercising muscles to produce more free 365 
radicals [3, 11]. This is likely to result in more cell damage and 366 
disruption to skeletal muscle contraction and an increased need for 367 
exogenous AOs [3, 11]. It is therefore possible that the AO effects of 368 
PYC-B were only significant at this time when skeletal muscle 369 
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contractions were most likely to be compromised by increased 370 
oxidative stress [1, 3, 15].  371 
Performance may also have been enhanced by PYC-B through 372 
increased blood flow, since the release of the vasodilator NO and 373 
reductions in endothelial damage and platelet formation are some of 374 
the proposed benefits of PYC [4, 15, 29]. This increased blood flow 375 
may help to overcome any potential circulatory limitations towards 376 
the end of the TT, attenuating the diminishing O2 supply to the 377 
exercising muscles and maintaining force production during the final 378 
5 km [6, 30].  Support for these mechanisms is provided by various 379 
studies of the physiological effects of PYC and bioflavonoids [29, 31].  380 
Both supplements had no effect on Blac levels at 40, 50, 60 and 70% 381 
of Wmax and 19.5 km into the TT. These results are comparable to 382 
previous studies that found consuming polyphenol supplements had 383 
no effect on Blac levels throughout and after HI cycling exercise [2, 384 
17]. One study however, found that Blac levels were reduced by 385 
ingesting a pre-trial AO and PYC beverage when cycling at a fixed 386 
output of 70% of Wmax [18]. It was proposed that the polyphenols 387 
within PYC encourage lactate removal, possibly via the vasodilatory-388 
induced increases in blood flow [18, 29]. Whether this effect occurs 389 
has not been investigated and requires more research. 390 
The supplements had no effect on RER when cycling at 40, 50, 60 391 
and 70% of Wmax. Another study also found that substrate use was 392 
unaffected by AO-rich quercetin consumption during a 30 km cycling 393 
TT [9]. In two other studies, no significant differences were found, but 394 
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there was a slight reduction in RER throughout running exercise after 395 
ingesting a pre-trial dose of Ecklonia cava [4] and a cocoa 396 
polyphenol supplement prior to cycling exercise [2]. Only studies 397 
using polyphenol mixtures such as green tea, which contains 398 
epigallocatechin gallate, have found significant increases in fat 399 
oxidation during exercise [32, 33]. 400 
The CHA and PYC-B supplements also had no effect on GME and 401 
VO2 (Lmin¹) (Table 2). Few studies investigating polyphenols and 402 
exercise performance have measured efficiency. Although one study 403 
found that VO2 was lower throughout a 30 km TT following ingestion 404 
of an AO and quercetin supplement GME was not calculated [9]. 405 
How polyphenols contribute to superior efficiency remains unclear, 406 
other studies investigating nitrate consumption have implied that 407 
boosting NO production could lower VO2, leading to improved 408 
exercise efficiency [34, 35]. Based on this, it is possible that in this 409 
study the polyphenol supplements effects on NO were insufficient to 410 
make any major difference to efficiency, however NO was not 411 
measured.  412 
Further research to help explain the results should be undertaken as 413 
no measures of FR damage or muscle blood flow were taken 414 
throughout the TT and therefore it can only be speculated that this 415 
was the case during the final 5 km. Furthermore, an optimal dosage 416 
of PYC-B and CHA has not yet been determined and it is 417 
conceivable that for an exercise protocol of this volume and intensity 418 
a greater daily dose and/or longer supplementation period is required 419 
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for both supplements to have a significant impact on performance, 420 
particularly during the CHA trial and should be the focus of future 421 
research. It should also be considered that the low sample size may 422 
have confounded the results, as VO2, RER and GME data was only 423 
available for 6 participants, a recognized limitation of this study. 424 
Future research should build upon these findings and employ 425 
designs with greater participant numbers.  426 
Conclusion 427 
To conclude, neither the PYC-B nor CHA polyphenol supplement 428 
significantly enhanced 20 km TT performance or had any 429 
physiological effect during sub-maximal cycling. PYC-B enhanced 430 
final 5 km power output suggesting that the supplement may provide 431 
some benefit towards the end of an intense bout of exercise. 432 
However as total 20 km time was not significantly different between 433 
trials the dosing protocol employed does not appear to benefit 20 km 434 
cycling time trial performance. Future studies should focus on using a 435 
greater dosage of the supplements and also the use of longer 436 
performance tests to see if further beneficial effects can be revealed 437 
under these conditions.  438 
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